Amalio Telenti graduated from the Faculty of Medicine of the University of Oviedo in 1983 and has a doctorate in microbiology from the University of Zaragoza (2000). He currently works as chief data scientist of the Scripps Translational Science Institute and as professor of Genomics in the The Scripps Research Institute. Both institutes are located in San Diego, US. Telenti joined the Scripps Research Institutes after a long and successful career. Previous to these appointments, he was Chief Scientific Officer at Human Longevity Inc., where he led the analysis of the first 10,000 deep sequenced human genomes and he researched the mechanisms by which genetic variations shorten life. His work in Switzerland is also worth mentioning. He served there as Professor and Director of the Institute of Microbiology of the University of Lausanne. He is member of the Scientific Advisory Board of the Center for Integrative Genomics of that university and of the Swiss Academy of Medical Sciences. In addition, he is the recipient of the Swiss Cloetta Award in Medicine and of the Research Award of the European Society for Microbiology and Infectious Diseases.
María Blasco Marhuenda
She was born in San Vicent del Raspeig, Alicante, in 1965 and she holds a PhD in Biochemistry and Molecular Biology. She was a pupil of Margarita Salas, a pioneering researcher in those fields and she has also worked with Carol W. Greider, who received the Nobel Prize in Medicine in 2009, in the prestigious Cold Spring Harbor Laboratory of New York. Her research has mainly focused on telomeres and telomerase, which are closely linked to the ageing process and the diseases associated with it. As for her professional career in Spain, she joined the Spanish National Research Council (CSIC) and led a team of researchers at the Department of Immunology and Oncology of the National Centre for Biotechnology. She started working for the Spanish National Cancer Research Centre (CNIO), which she currently heads. She has received national and international awards, such as the Ramón y Cajal National Award for Research or the European Molecular Biology Organization (EMBO) Gold Medal for best European researcher under the age of 40.
Federico Pallardó Calatayud
He was born in Valencia in 1961, he is a Doctor of Medicine and Surgery, and Professor of Physiology at the University of Valencia (UV). He completed his education in prestigious universities of the United States and the United Kingdom. He is an expert in oxidative stress and its epigenetic regulation, as well as in pathophysiology of rare diseases. In addition to his research and dissemination work, he has headed the Central Unit of Research, coordinated the basic research laboratories INCLIVA for over ten years and he held the position of secretary at the Society for Free Radical Research (SFRR) Europe. Currently he is a member of the advisory council of the Valencian Foundation for Advanced Studies (FVEA), of the expert committee of the Príncipe Felipe Science Museum, as well as team leader of the Biomedical Research Networking Center (CIBER) rare diseases division.
Manuel Perez Alonso
He holds a PhD in Biology and he is a Professor of Genetics at the University of Valencia. His research focuses on molecular genetics and genomic applied to medicine. He is known for his outreach work. He is the author of more than 50 research papers on his field of expertise, including three articles published by the prestigious journal Nature. As a scientific entrepreneur, he is a founding partner of the company Sistemas Genómicos (Genomic Systems), Valentia BioPharma and the Genomic Medicine Institute, among others.
Graduated in Biomedical Sciences at the University of Navarra, Manuel Corpas focused in the human genome since the very beginning of his career. He has worked in the National Institute of Bioinformatics and the Sanger Institute of genome analysis. Besides, he has lead a research about animal and plant’s genome in The Genome Analysis Center. Last 2016 he joined Repositive, a start-up specialized in sharing and storing genomes of different types. The aim is expanding and disseminating the expertise of this field of science. Now he is the CEO/Founder of Cambridge Precision Medicine.
Santiago Grisolía García
Born in Valencia in 1923 and Doctor of Medicine. His scientific contribution to biochemistry in general and enzymology in particular is remarkable. In 1945, received a scholarship which allowed him to complete his education in the United States, where he also collaborated with Severo Ochoa. Ever since, he developed his professional career in different prestigious universities of the United States. He has established well-known institutions such as the Valencian Foundation for Advanced Studies (FVEA) and he has received the Prince of Asturias Award among other prestigious awards. He is also an Honorary Doctor of several universities, member of renowned international scientific associations and chairman of the Scientific Committee of the Human Genome Project for UNESCO.